About Permides

PERMIDES is one out of five European INNOSUP-1-2015 – Cluster facilitated projects for new value chains projects (funded under EC Call for proposal: H2020-INNOSUP-2015-1).

It is the aim of PERMIDES to strengthen the competitiveness and foster the innovation potential of Personalized Medicine as an Emerging Industry in Europe by providing key solutions for the reconfiguration of the biopharmaceutical value chain towards a Health Economy 4.0 with a special focus on oncology (i.e. cancer treatment). Current value chain challenges lie in e.g. data gathering and exchange, big data and machine learning, or new software-based marketing methods based.

Via a cross-clustering approach, leading biopharma and IT clusters from three countries (Austria, Germany and
Norway) will create novel cross-sectoral collaborations between SMEs to address innovation barriers in the biopharma sector via cutting-edge IT solutions. As a cross-cutting industry, the ICT and software sector is an enabler of innovation in many industries and therefore provides a broad knowledge base of processes and best practice solutions in diverse industrial contexts and business environments.

Download PERMIDES Strategy Document D1.3

“We are very satisfied with the platform and already started discussion with one company for a collaboration on a mutually interesting and very innovative project.” Marco Roccato, MediSapiens; Finland

PERMIDES Platform open since

Working together with @PERMIDES_EU to bring a unique conference - Empowering #personalizedmedicine Through Digital Solutions. Followed by Benelux Precision Medicine Forum it looks set to be a great couple of days in #Utrecht https://t.co/yDGpuIRleE

"Empowering Personalized Medicine through Digital Solutions" - #PERMIDES Final Conference, 12 June 2018.

Our speakers: https://t.co/RiJ0LZb3eo

@EU_H2020 @DSMeu @EU_Growth #H2020 #personalizedmedicine @precisionforum